Medicine changes lives.
Research changes the world.
Every day, Mass General Brigham scientists chart new terrain in biomedical research to prevent and treat human disease and advance patient care — locally and across the globe.
Recent News
Innovative Service at Mass General Brigham Encourages Research Labs to Embrace Sustainability
How a consultation service at Mass General Brigham is helping research labs go green and embrace sustainability in their science.
Tracking Differences in “Time to Surgery” for Breast Cancer Patients Could Reduce Disparities and Improve Outcomes
A recent study both validated time to surgery as a standardized metric for breast cancer care and identified a worrying difference in time to surgery between Black and white patients.
Snapshot of Science: Mass General’s High Impact Research Publications for March 2024
Increase the sensitivity of liquid biopsies, neurons in the human brain able to predict what we’re going to say before we say it and much more
The Astonishing Team Effort that Led to the First Trial of CAR T Cells for Glioblastoma at Mass General Brigham
It took contributions from almost 100 people to translate promising lab findings into a first-in-human treatment for glioblastoma.
Mass General Researchers Share the Science of Sleep Health
Mass General researchers and clinicians share science-backed findings about the importance of sleep health.
Why Are More Young Adults Getting Colorectal Cancer? New Grant Will Support the Quest to Find Out
Cancer Grand Challenges: Record £100m awarded to five teams taking on cancer’s toughest challenges, including Andrew Chan, MD, MPH, from Massachusetts General Hospital.
Snapshot of Science: Mass General’s High Impact Research Publications for February 2024
Increase the sensitivity of liquid biopsies, neurons in the human brain able to predict what we’re going to say before we say it and much more
Rare Diseases Day: Q&A with a Mass General Investigator
Vanessa Merker,PhD, has spent her 14-year career at Mass General working to improve care for patients with schwannomatosis and NF2.